Xu, Kai, Xiao, Zhiyan, Tang, Yan Bo, Huang, Li, Chen, Chin-Ho, Ohkoshi, Emika, and Lee, Kuo-Hsiung
Abstract: Fourteen naphthoquinone derivatives (1–14) were designed based on a putative proteasome inhibitor PI-083. These compounds were synthesized and evaluated against A549, DU145, KB, and KBvin tumor cell lines. Six compounds (2, 4, 8, 9, 10, and 13) showed antiproliferative activities comparable to that of PI-083. Among them, compound 8 was confirmed as a 20S proteasome inhibitor in both in vitro and cell-based assays. These findings endorse further optimization efforts based on this structural phenotype to develop potential anticancer drug candidates. [Copyright &y& Elsevier]